Altaris Capital Partners to acquire Perrigo Rx business for $1.5bn
Altaris Capital Partners has agreed to acquire the prescription pharma (Rx) business of Perrigo Company plc, an Ireland-based pharma company, for about $1.55 billion. The Rx business of Perrigo employs over 1,300 employees in six locations in the US and Israel. Its generic medicines portfolio consists of more than 200 product families and 800 stock-keeping […]